3results about How to "Restore color" patented technology

This invention provides the application of lecithin in the preparation of drugs for the prevention and / or treatment of infertility, belonging to the field of biomedical preparation technology. Specifically, it relates to the application of lecithin in the preparation of drugs for the prevention and / or treatment of infertility, recurrent miscarriage, and / or uterine decidualization disorders. The lecithin can effectively reduce TNF-α levels in early pregnancy, improve uterine decidualization disorders, and increase endometrial receptivity, thereby increasing pregnancy rates and providing a new approach for the treatment of infertility and recurrent miscarriage.

The invention relates to the technical field of daily chemicals, in particular to an antibacterial linen detergent which comprises a surfactant, a builder, a unique composite antibacterial system and a composite biological enzyme preparation. The composite antibacterial system is formed by compounding a double-chain quaternary ammonium salt, a guanidine polymer and a plant-source antibacterial synergist according to a specific proportion, the composite antibacterial system and a biological enzyme preparation containing protease, lipase, amylase and cellulase generate a synergistic effect, and through a mechanism of first enzymolysis cleaning and then multi-target synergistic sterilization, the composite antibacterial system can be used for preparing a multi-target antibacterial agent under the low-temperature condition of 40-60 DEG C; the efficient decontamination on the linen and the broad-spectrum and lasting killing on bacteria and fungi can be realized, and the drug resistance risk of microorganisms is obviously reduced. The product does not contain a chlorine bleaching agent, is environment-friendly and safe, has small damage to fabrics, and is particularly suitable for hygienic washing of linen in the industries of hotels, hospitals and the like.

The application provides an effect and application of CREPT in fatty liver disease and complications thereof, in particular, application of CREPT gene or protein as a target or a reagent for targeting the CREPT gene or protein in treatment of metabolic-related fatty liver disease and fatty liver disease complications or in preparation of a medicine for treating metabolic-related fatty liver disease and fatty liver disease complications, and the metabolic-related fatty liver disease and fatty liver disease complications are treated by reducing the expression of the CREPT gene or reducing the function or inactivating the CREPT protein. The present application firstly finds that the CREPT is closely related to the metabolic-related fatty liver disease: the systemic or local medication can effectively treat the metabolic-related fatty liver disease and fatty liver disease complications by reducing the expression of the CREPT.